vs

Side-by-side financial comparison of Stanley Black & Decker (SWK) and Stryker Corporation (SYK). Click either name above to swap in a different company.

Stryker Corporation is the larger business by last-quarter revenue ($7.2B vs $3.8B, roughly 1.9× Stanley Black & Decker). Stryker Corporation runs the higher net margin — 11.8% vs 1.4%, a 10.5% gap on every dollar of revenue. On growth, Stryker Corporation posted the faster year-over-year revenue change (11.4% vs 0.1%). Stryker Corporation produced more free cash flow last quarter ($1.9B vs $155.3M). Over the past eight quarters, Stryker Corporation's revenue compounded faster (16.9% CAGR vs 0.3%).

Stanley Black & Decker, Inc., formerly known as The Stanley Works, is an American manufacturer of industrial tools and household hardware, and a provider of security products. Headquartered in the Greater Hartford city of New Britain, Connecticut, Stanley Black & Decker is the result of the merger of The Stanley Works and Black & Decker on March 12, 2010.

The Stryker is a family of eight-wheeled armored fighting vehicles derived from the Canadian LAV III, which in turn derived from the Swiss Mowag Piranha. Stryker vehicles are produced by General Dynamics Land Systems-Canada (GDLS-C) for the United States Army in a plant in London, Ontario. It has four-wheel drive (8×4) and can be switched to all-wheel drive (8×8).

SWK vs SYK — Head-to-Head

Bigger by revenue
SYK
SYK
1.9× larger
SYK
$7.2B
$3.8B
SWK
Growing faster (revenue YoY)
SYK
SYK
+11.3% gap
SYK
11.4%
0.1%
SWK
Higher net margin
SYK
SYK
10.5% more per $
SYK
11.8%
1.4%
SWK
More free cash flow
SYK
SYK
$1.7B more FCF
SYK
$1.9B
$155.3M
SWK
Faster 2-yr revenue CAGR
SYK
SYK
Annualised
SYK
16.9%
0.3%
SWK

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
SWK
SWK
SYK
SYK
Revenue
$3.8B
$7.2B
Net Profit
$51.4M
$849.0M
Gross Margin
31.4%
64.5%
Operating Margin
25.2%
Net Margin
1.4%
11.8%
Revenue YoY
0.1%
11.4%
Net Profit YoY
-43.6%
55.5%
EPS (diluted)
$0.34
$2.20

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
SWK
SWK
SYK
SYK
Q4 25
$7.2B
Q3 25
$3.8B
$6.1B
Q2 25
$3.9B
$6.0B
Q1 25
$3.7B
$5.9B
Q4 24
$3.7B
$6.4B
Q3 24
$3.8B
$5.5B
Q2 24
$4.0B
$5.4B
Q1 24
$3.9B
$5.2B
Net Profit
SWK
SWK
SYK
SYK
Q4 25
$849.0M
Q3 25
$51.4M
$859.0M
Q2 25
$101.9M
$884.0M
Q1 25
$90.4M
$654.0M
Q4 24
$194.9M
$546.0M
Q3 24
$91.1M
$834.0M
Q2 24
$-11.2M
$825.0M
Q1 24
$19.5M
$788.0M
Gross Margin
SWK
SWK
SYK
SYK
Q4 25
64.5%
Q3 25
31.4%
63.6%
Q2 25
27.0%
63.8%
Q1 25
29.9%
63.8%
Q4 24
30.8%
64.9%
Q3 24
29.9%
64.0%
Q2 24
28.4%
63.0%
Q1 24
28.6%
63.6%
Operating Margin
SWK
SWK
SYK
SYK
Q4 25
25.2%
Q3 25
18.7%
Q2 25
18.5%
Q1 25
14.3%
Q4 24
3.4%
9.0%
Q3 24
10.6%
19.7%
Q2 24
9.5%
19.4%
Q1 24
8.3%
18.5%
Net Margin
SWK
SWK
SYK
SYK
Q4 25
11.8%
Q3 25
1.4%
14.2%
Q2 25
2.6%
14.7%
Q1 25
2.4%
11.1%
Q4 24
5.2%
8.5%
Q3 24
2.4%
15.2%
Q2 24
-0.3%
15.2%
Q1 24
0.5%
15.0%
EPS (diluted)
SWK
SWK
SYK
SYK
Q4 25
$2.20
Q3 25
$0.34
$2.22
Q2 25
$0.67
$2.29
Q1 25
$0.60
$1.69
Q4 24
$1.29
$1.41
Q3 24
$0.60
$2.16
Q2 24
$-0.07
$2.14
Q1 24
$0.13
$2.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
SWK
SWK
SYK
SYK
Cash + ST InvestmentsLiquidity on hand
$268.3M
$4.0B
Total DebtLower is stronger
$5.3B
Stockholders' EquityBook value
$9.0B
$22.4B
Total Assets
$21.8B
$47.8B
Debt / EquityLower = less leverage
0.59×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
SWK
SWK
SYK
SYK
Q4 25
$4.0B
Q3 25
$268.3M
$3.3B
Q2 25
$311.8M
$2.4B
Q1 25
$344.8M
$2.3B
Q4 24
$290.5M
$3.7B
Q3 24
$298.7M
$3.9B
Q2 24
$318.5M
$1.9B
Q1 24
$476.6M
$2.3B
Total Debt
SWK
SWK
SYK
SYK
Q4 25
Q3 25
$5.3B
Q2 25
$5.6B
Q1 25
$5.6B
Q4 24
$6.1B
Q3 24
$6.1B
Q2 24
$6.1B
Q1 24
$6.1B
Stockholders' Equity
SWK
SWK
SYK
SYK
Q4 25
$22.4B
Q3 25
$9.0B
$21.8B
Q2 25
$9.1B
$21.2B
Q1 25
$8.8B
$20.9B
Q4 24
$8.7B
$20.6B
Q3 24
$8.9B
$20.1B
Q2 24
$8.7B
$19.8B
Q1 24
$8.9B
$19.2B
Total Assets
SWK
SWK
SYK
SYK
Q4 25
$47.8B
Q3 25
$21.8B
$47.1B
Q2 25
$22.5B
$46.3B
Q1 25
$22.5B
$46.0B
Q4 24
$21.8B
$43.0B
Q3 24
$22.5B
$43.8B
Q2 24
$22.5B
$39.1B
Q1 24
$23.9B
$39.4B
Debt / Equity
SWK
SWK
SYK
SYK
Q4 25
Q3 25
0.59×
Q2 25
0.62×
Q1 25
0.63×
Q4 24
0.70×
Q3 24
0.69×
Q2 24
0.70×
Q1 24
0.69×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
SWK
SWK
SYK
SYK
Operating Cash FlowLast quarter
$221.2M
$2.1B
Free Cash FlowOCF − Capex
$155.3M
$1.9B
FCF MarginFCF / Revenue
4.1%
26.1%
Capex IntensityCapex / Revenue
1.8%
3.7%
Cash ConversionOCF / Net Profit
4.30×
2.52×
TTM Free Cash FlowTrailing 4 quarters
$369.6M
$4.3B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
SWK
SWK
SYK
SYK
Q4 25
$2.1B
Q3 25
$221.2M
$1.5B
Q2 25
$214.3M
$1.1B
Q1 25
$-420.0M
$250.0M
Q4 24
$679.1M
$1.9B
Q3 24
$285.8M
$1.5B
Q2 24
$573.0M
$633.0M
Q1 24
$-431.0M
$204.0M
Free Cash Flow
SWK
SWK
SYK
SYK
Q4 25
$1.9B
Q3 25
$155.3M
$1.4B
Q2 25
$134.7M
$928.0M
Q1 25
$-485.0M
$127.0M
Q4 24
$564.6M
$1.7B
Q3 24
$199.3M
$1.3B
Q2 24
$485.8M
$481.0M
Q1 24
$-496.7M
$37.0M
FCF Margin
SWK
SWK
SYK
SYK
Q4 25
26.1%
Q3 25
4.1%
22.3%
Q2 25
3.4%
15.4%
Q1 25
-13.0%
2.2%
Q4 24
15.2%
25.9%
Q3 24
5.3%
23.7%
Q2 24
12.1%
8.9%
Q1 24
-12.8%
0.7%
Capex Intensity
SWK
SWK
SYK
SYK
Q4 25
3.7%
Q3 25
1.8%
3.1%
Q2 25
2.0%
3.0%
Q1 25
1.7%
2.1%
Q4 24
3.1%
4.1%
Q3 24
2.3%
3.1%
Q2 24
2.2%
2.8%
Q1 24
1.7%
3.2%
Cash Conversion
SWK
SWK
SYK
SYK
Q4 25
2.52×
Q3 25
4.30×
1.79×
Q2 25
2.10×
1.26×
Q1 25
-4.65×
0.38×
Q4 24
3.48×
3.54×
Q3 24
3.14×
1.77×
Q2 24
0.77×
Q1 24
-22.10×
0.26×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

SWK
SWK

Tools And Outdoor Segment$3.3B87%
Engineered Fastening Segment$500.5M13%

SYK
SYK

Medical$1.3B18%
Endoscopy$1.1B16%
Traumaand Extremities$1.1B15%
Instruments$925.0M13%
Knees$749.0M10%
Neuro Cranial$669.0M9%
Neurovascular$539.0M8%
Hips$499.0M7%
Other Orthopaedics$267.0M4%
Spine$8.0M0%

Related Comparisons